240 related articles for article (PubMed ID: 30568991)
1. CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection.
Gisslén M; Heslegrave A; Veleva E; Yilmaz A; Andersson LM; Hagberg L; Spudich S; Fuchs D; Price RW; Zetterberg H
Neurol Neuroimmunol Neuroinflamm; 2019 Jan; 6(1):e512. PubMed ID: 30568991
[TBL] [Abstract][Full Text] [Related]
2. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.
Jessen Krut J; Mellberg T; Price RW; Hagberg L; Fuchs D; Rosengren L; Nilsson S; Zetterberg H; Gisslén M
PLoS One; 2014; 9(2):e88591. PubMed ID: 24523921
[TBL] [Abstract][Full Text] [Related]
3. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.
McGuire JL; Gill AJ; Douglas SD; Kolson DL;
J Neurovirol; 2015 Aug; 21(4):439-48. PubMed ID: 25776526
[TBL] [Abstract][Full Text] [Related]
4. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
[TBL] [Abstract][Full Text] [Related]
5. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers.
Suárez-Calvet M; Kleinberger G; Araque Caballero MÁ; Brendel M; Rominger A; Alcolea D; Fortea J; Lleó A; Blesa R; Gispert JD; Sánchez-Valle R; Antonell A; Rami L; Molinuevo JL; Brosseron F; Traschütz A; Heneka MT; Struyfs H; Engelborghs S; Sleegers K; Van Broeckhoven C; Zetterberg H; Nellgård B; Blennow K; Crispin A; Ewers M; Haass C
EMBO Mol Med; 2016 May; 8(5):466-76. PubMed ID: 26941262
[TBL] [Abstract][Full Text] [Related]
6. Increased CSF Soluble TREM2 Concentration in Patients With Neurosyphilis.
Li W; Chang H; Wu W; Xu D; Jiang M; Gao J; Huang Y; Xu Y; Yin L; Zhang X
Front Neurol; 2020; 11():62. PubMed ID: 32117023
[No Abstract] [Full Text] [Related]
7. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.
Heslegrave A; Heywood W; Paterson R; Magdalinou N; Svensson J; Johansson P; Öhrfelt A; Blennow K; Hardy J; Schott J; Mills K; Zetterberg H
Mol Neurodegener; 2016 Jan; 11():3. PubMed ID: 26754172
[TBL] [Abstract][Full Text] [Related]
8. Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
Gisslen M; Keating SM; Spudich S; Arechiga V; Stephenson S; Zetterberg H; Di Germanio C; Blennow K; Fuchs D; Hagberg L; Norris PJ; Peterson J; Shacklett BL; Yiannoutsos CT; Price RW
PLoS One; 2021; 16(5):e0250987. PubMed ID: 33983973
[TBL] [Abstract][Full Text] [Related]
9. Glial activation and inflammation along the Alzheimer's disease continuum.
Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
[TBL] [Abstract][Full Text] [Related]
10. The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer's disease.
Park SH; Lee EH; Kim HJ; Jo S; Lee S; Seo SW; Park HH; Koh SH; Lee JH
Sci Rep; 2021 Jun; 11(1):13050. PubMed ID: 34158530
[TBL] [Abstract][Full Text] [Related]
11. Associations of Sleep Characteristics with Cerebrospinal Fluid sTREM2 in Cognitively Normal Older Adults: the CABLE Study.
Hu HY; Ma LZ; Hu H; Bi YL; Ma YH; Shen XN; Ou YN; Dong Q; Tan L; Yu JT
Neurotox Res; 2021 Aug; 39(4):1372-1380. PubMed ID: 34097185
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study.
Ma LZ; Tan L; Bi YL; Shen XN; Xu W; Ma YH; Li HQ; Dong Q; Yu JT
Mol Neurodegener; 2020 Apr; 15(1):25. PubMed ID: 32276587
[TBL] [Abstract][Full Text] [Related]
13. CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum.
Rauchmann BS; Schneider-Axmann T; Alexopoulos P; Perneczky R;
Neurobiol Aging; 2019 Feb; 74():182-190. PubMed ID: 30458365
[TBL] [Abstract][Full Text] [Related]
14. CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.
Abdulle S; Mellgren A; Brew BJ; Cinque P; Hagberg L; Price RW; Rosengren L; Gisslén M
J Neurol; 2007 Aug; 254(8):1026-32. PubMed ID: 17420923
[TBL] [Abstract][Full Text] [Related]
15. TREM2 expression in the brain and biological fluids in prion diseases.
Diaz-Lucena D; Kruse N; Thüne K; Schmitz M; Villar-Piqué A; da Cunha JEG; Hermann P; López-Pérez Ó; Andrés-Benito P; Ladogana A; Calero M; Vidal E; Riggert J; Pineau H; Sim V; Zetterberg H; Blennow K; Del Río JA; Marín-Moreno A; Espinosa JC; Torres JM; Sánchez-Valle R; Mollenhauer B; Ferrer I; Zerr I; Llorens F
Acta Neuropathol; 2021 Jun; 141(6):841-859. PubMed ID: 33881612
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.
Piccio L; Deming Y; Del-Águila JL; Ghezzi L; Holtzman DM; Fagan AM; Fenoglio C; Galimberti D; Borroni B; Cruchaga C
Acta Neuropathol; 2016 Jun; 131(6):925-33. PubMed ID: 26754641
[TBL] [Abstract][Full Text] [Related]
17. Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury.
Suárez-Calvet M; Araque Caballero MÁ; Kleinberger G; Bateman RJ; Fagan AM; Morris JC; Levin J; Danek A; Ewers M; Haass C;
Sci Transl Med; 2016 Dec; 8(369):369ra178. PubMed ID: 27974666
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers.
Ashton NJ; Suárez-Calvet M; Heslegrave A; Hye A; Razquin C; Pastor P; Sanchez-Valle R; Molinuevo JL; Visser PJ; Blennow K; Hodges AK; Zetterberg H
Alzheimers Res Ther; 2019 Nov; 11(1):94. PubMed ID: 31779670
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.
Guha D; Mukerji SS; Chettimada S; Misra V; Lorenz DR; Morgello S; Gabuzda D
AIDS; 2019 Mar; 33(4):615-625. PubMed ID: 30557159
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid tau, Aβ, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration.
Alosco ML; Tripodis Y; Fritts NG; Heslegrave A; Baugh CM; Conneely S; Mariani M; Martin BM; Frank S; Mez J; Stein TD; Cantu RC; McKee AC; Shaw LM; Trojanowski JQ; Blennow K; Zetterberg H; Stern RA
Alzheimers Dement; 2018 Sep; 14(9):1159-1170. PubMed ID: 30049650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
